Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
DBVT

DBV Technologies (DBVT) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $9.80 +2.6% on the day -38.2% over 12 months 52-week range $9.55 – $24.54

Share price and insider trades

DBVT closeInsider buyInsider sale
510152025NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $1,253 on 2026-07-29 · Pharis MohideenSold $2,595 on 2026-01-29 · Pharis MohideenSold $4,498 on 2025-11-21 · Pharis MohideenSold $18,708 on 2025-11-20 · Pharis MohideenSold $5,413,912 on 2025-12-18 · Bpifrance EpicSold $10,070,232 on 2025-12-17 · Bpifrance Epic
Bought, 12 months$0
Sold, 12 months$15.5M
Insiders buying0
Insiders selling2

DBV Technologies insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $15.5M of DBVT stock on the open market.

DBVT insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $15.5M sold (5 trades)Q4 2025Q1 2026: $3K sold (1 trades)Q1 2026Q2 2026Q3 2026: $1K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$1K1
Q2 2026—0—0
Q1 2026—0$3K1
Q4 2025—0$15.5M5

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 DBV Technologies S.A. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $15.5M. 0 of 7 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 31SEC Pharis MohideenChief Medical Officer Sell 464144,531 held (−0%) $2.70 $1K +263.0% —
Feb 2SEC Pharis MohideenChief Medical Officer Sell 534144,995 held (−0%) $4.86 $3K +101.6% —
Dec 19SEC Bpifrance EpicMember Of 10% Owner Group Sell 2,036,9908,635,472 held (−19%) $4.84 $9.9M +102.5% —
Dec 19SEC Bpifrance EpicMember Of 10% Owner Group Sell 1,292,1037,303,369 held (−15%) $4.19 $5.4M +133.9% —
Dec 19SEC Bpifrance EpicMember Of 10% Owner Group Sell 40,0008,595,472 held (−0%) $5.28 $211K +85.6% —
Nov 25SEC Pharis MohideenChief Medical Officer Sell 6,496103,153 held (−6%) $2.88 $19K +240.3% —
Nov 25SEC Pharis MohideenChief Medical Officer Sell 1,624101,529 held (−2%) $2.77 $4K +253.8% —

Insiders at DBV Technologies S.A.

InsiderBoughtSoldLast filingScore
Bpifrance EpicMember Of 10% Owner Group — $15.5M Dec 19, 2025 —
Pharis MohideenChief Medical Officer — $27K Jul 31, 2026 —

DBVT stock: common questions

Are DBV Technologies S.A. insiders buying DBVT stock?

In the past 12 months, 0 insiders reported open-market purchases of DBVT worth $0.

Are DBV Technologies S.A. insiders selling DBVT stock?

2 insiders reported sales worth $15.5M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is DBVT's 52-week range?

Over the past year DBVT has traded between $9.55 and $24.54. It last closed at $9.80 on Oct 9, 2026.